BIO TECH
Biotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.
We implement the technologies and thoughts of entrepreneurs and researchers in the biotech field into society together.
Biotech Grand Prix 2024
Standing up for solutions to society's problemsBiotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.
We implement the technologies and thoughts of entrepreneurs and researchers in the biotech field into society together.
NEWS
News
2024/04/08
TECH PLANTER revamps its logo and evolves into a mechanism to further accelerate business creation.
- Agritech Grand Prix
- Ecotech Grand Prix
- Grand Prix
- Deep Tech Grand Prix
- News
- Biotech Grand Prix
- Food Tech Grand Prix
- Marintec Grand Prix
- Lifetech Grand Prix
2023/12/04
Tech Planter 2024 call for entries is now open!
- Agritech Grand Prix
- Ecotech Grand Prix
- Grand Prix
- Deep Tech Grand Prix
- News
- Biotech Grand Prix
- Food Tech Grand Prix
- Marintec Grand Prix
- Lifetech Grand Prix
2023/09/26
Biotech Grand Prix 2023 Preliminary Report: Grand Prize Won by Mormill, Inc.
- Grand Prix
- News
- Biotech Grand Prix
2022/09/26
Biotech Grand Prix 2022 Preliminary Report: the Grand Prize goes to MBF
- News
- Biotech Grand Prix
ABOUT
Outline of the event
- point (e.g. of a statement)
- Scientific and technological "seeds" are being created in universities, research institutes, and corporate laboratories, but it takes a lot of effort before they sprout into practical applications. The "Tech Planter," organized by LIVERNESS and its partners, is an ecosystem designed to serve as a planter to discover these seeds and help them sprout into business. The Biotech Grand Prix is a program aimed at discovering and fostering technology seeds and entrepreneurs in the real tech field (biotechnology, healthcare, medicine, drug discovery, medical devices, research tools, etc.).
Related Grand Prix :. List of Biotech Grand Prix - subject (of taxation, etc.)
-
- Those who have a vision to change the world or improve the world based on the technological seeds in the real tech field and have a will to establish or develop a new business.
- Individuals and teams are both welcome to participate, even before incorporation.
- No limitation on the number of years of establishment, even if you are already a corporation. Even if you are close to mass production or PMF establishment, if you are planning to collaborate with partner companies, etc., it is acceptable.
- Application Theme
- Biotechnologies supporting the environment, energy, food, agriculture, medicine and health, etc.
- Application period
- Friday, December 1, 2023 - Friday, July 5, 2024
- Screening Criteria
-
A panel of judges composed of LIVERNESS and its partners will review the following items
- 01novelty (patentability)
- 02feasibility
- 03Overseas Expansion Capabilities
- 04Are you going to change the world?
- 05passion
- commendation
- Grand Prize: (300,000 yen cash prize + right to receive 5 million yen business investment) 1
Corporate Prize: (200,000 yen) Approximately 10 prizes will be awarded.
SCHEDULE
Schedule
- 12/1[FRI].
-
Entry Start
this way (direction close to the speaker or towards the speaker)Please register as a member and fill out the web form to apply. We also hold information sessions at universities and on an individual basis to encourage determination to enter and to teach tips on how to prepare documents. Please feel free to contact us for more information.
- 6/22[SAT]
-
kickoff
RIVANES and its partners, as well as entered teams, will meet and mingle.
Business consultation and partnership development with each other will be available. Participation or lack of participation on the day of the event will not be considered.
- 7/7[SUN].
-
1st round: Application Screening
A panel of judges composed of LIVERNESS and its partners will review the documents.
You will be asked to submit information about your team, skills, passions, and vision for the future via web form and video.
All applicants will be notified of the screening results and provided with feedback on their applications.
In addition, individual interviews (also online) for presentation review will be conducted for those who wish to participate.
- 8monthfirst 10 days of month
-
Finalists determined
Interviews will be held for applicants who pass the document screening to brush up their presentations for the final round.
In addition, meetings can be set up with partner companies for the purpose of business consultation and developing partnerships.
- 10/12[SAT]
-
Biotech Grand Prix
The 12 finalist teams that pass the document screening will be screened for presentation.
- 10Month～
-
Cooperation Discussion
After the Demo Day, the contact point between the venture and LIBANES will continue to be open for discussions on commercialization.
We handle a wide range of start-up issues, from incorporation to prototype development, financing, R&D, and more.
In addition, collaborative matching between ventures and partner companies has become more active to support business development.
PARTNER
Coming soon
Partners
ASSET
asset
- ASSET01Riverness Communicator
- ASSET02Partners
- ASSET03Professional Supporter
- ASSET04superfactory group
SUPPORT
Support
- SUPPORT01Organize the purpose and vision of starting a business
- SUPPORT02Brush up on your presentation
- SUPPORT03Providing opportunities for business company collaboration
- SUPPORT04Support for R&D and prototype development
- SUPPORT05Support for knowledge and IP strategies
- SUPPORT06finance
DEMO DAY
Grand Prix Outline
- Grand Prix Name
- Biotech Grand Prix 2024
- Location
- center of a garage (1-16-3 Yokogawa, Sumida-ku, Tokyo)
- Date & Time
- Saturday, October 12, 2024, 13:00-19:00
- Application period
- Friday, December 1, 2023 - Friday, July 5, 2024
- Participation Target
- Held on a closed, pre-registration basis (finalists, partner companies, professional supporters, Super Factory Group)
- organizing
- LIVERNESS Corporation
- timeline
-
- 12:30-13:00
- inauguration
- 13:00-13:30
- Greetings from the Organizer
- 13:30-17:00
- Presentation (Presenter①～⑫)
- 17:00-18:00
- Review Time
- 18:00-19:00
- Announcement of Judging Results and Award Ceremony
JUDGE
Coming soon
judge
FINALIST
finalist
-
- Good Hero Therapeutics, Inc.
- Representative】Seshiyuki Miyagawa
Development of Innovative Modalities in Gene Therapy
The company aims to create new gene and virus therapies and a world without intractable diseases by making full use of technologies for detoxifying gene therapy vectors, infecting targeted cells with viruses, and improving vector productivity. -
- Applied FUSION Technology, Inc.
- Representative] Itaru Motojima
Practical Application of Virus Inactivation Device Using Fusion Technology
Applying technology derived from nuclear fusion research, the company has succeeded in developing a compact and lightweight device that inactivates viruses of 99.991 TP3T or higher. The device adsorbs and inactivates airborne viruses for applications such as ambulances and home air conditioners, contributing to the safety of people's lives and emergency medical care sites. -
- Illumi Medical, Inc.
- Representative] Toshihiko Tsukamoto
Development of the world's first treatment method to deliver light deep inside the body from within blood vessels
As a new treatment method that can be delivered to patients with diseases and debilitating physical conditions for which there is currently no treatment method, we will develop a new system and device that irradiates light to affected areas deep inside the body via blood vessels that stretch throughout a person's body, revolutionizing the concept of treatment and drug discovery. -
- NERON Corporation
- Representative] Yasuhisa Nagasaki
Mental Well-being Enterobacterial Cocktail for Space Adaptation
To develop a cocktail of intestinal microflora for mental well-being that can be easily used daily by people who are suffering from mental imbalance due to conflicts and economic instability. We aim to create a cocktail of multiple species of bacteria in a unique ratio and use them as viable bacteria. In the future, the company aims to develop the cocktail into a drug for unwellness. -
- Luna RD Corporation
- Representative] Takumi Sato
DDS development contributing to mRNA vaccines
DDS technology is essential for the practical use of nucleic acid medicine and mRNA vaccines, and we aim to develop lipid nanoparticles for nucleic acid delivery that are pH-responsive, stable under physiological conditions, and selectively effective at low concentrations for social implementation as DDS. -
- MatriSurge Corporation
- Representative] Hiroshi Yagi
Biocompatible hydrogel that "promotes self-renewal."
We have developed "organ decellularization technology" that removes all cells from tissues and efficiently extracts active ingredients, mainly collagen, and have succeeded in developing a new concept of hydrogel medical material that has the effect of promoting natural healing. -
- RMD Sciences, Inc.
- Representative] Akito Taira
Drug discovery that targets only specific intestinal bacterial species
The most effective way to target the gut microbiota is to orally selectively modulate the growth of specific bacterial species. However, due to the complexity of the intestinal microbiota, no one has been able to achieve this. RMD-101, a novel substance that makes this possible, will enable us to improve quality of life. -
- Antibiotic Adjuvant Technology
- Representative] Tomohiro Sawa
Adjuvant technology to save antimicrobials from resistance
Resistant bacteria are emerging at a faster pace than the development of antimicrobial agents. We aim to solve the problem of antimicrobial-resistant bacteria with technology that rapidly discovers, improves, and demonstrates the effectiveness of antimicrobial adjuvants, compounds that inhibit the mechanism of resistance and make antimicrobial agents effective again. -
- Beyond Optical Technologies
- Representative] Toshihiro Takamatsu
Next-generation endoscope system that visualizes the invisible depths
Developed the world's first endoscope system that utilizes near-infrared light, which is highly permeable to living organisms and can analyze components when spectroscopic, as a technology to visualize vital tissues such as blood vessels and nerves deep in the body that must not be removed during surgery. The system dramatically improves patient safety and the quality of surgery. -
- SPHinX
- Representative] Makoto Sasaki
Development of a simple diagnostic kit for infectious diseases that can be used in developing countries
The spread of accurate, simple, and inexpensive diagnostic methods is essential to solving the problem of infectious diseases in developing countries, but these methods do not yet exist. We will develop and disseminate a simple diagnostic kit for infectious diseases using our original smart polymers to achieve the eradication of infectious diseases in developing countries. -
- neomixel
- Representative] Daiki Watanabe
Culture simulator x Agitator without stirring rod
We propose a technique for mass culture of cells using numerical fluid dynamics simulation and a bioreactor without stirring rods. Both uniform mixing in the culture tank and low physical stress to the cells are realized. We also aim to realize quantitative prediction of culture performance using an ultra-high-precision simulator. -
- novisome
- Representative] Noriyuki Uchida
Membrane-deforming liposomes for efficient encapsulation of large biomolecules
Designing receptor molecules that assemble on the phospholipid membrane in response to stimuli and induce splitting of the liposome into its interior. By directly incorporating external solutions, they can be applied as carrier materials for detoxification of viruses and bacteria and highly efficient encapsulation of biological macromolecules such as antibodies.